Purple Biotech Ltd. (PPBT)
NASDAQ: PPBT · IEX Real-Time Price · USD
0.389
+0.009 (2.40%)
At close: Jul 26, 2024, 2:45 PM
0.412
+0.023 (5.91%)
After-hours: Jul 26, 2024, 7:33 PM EDT
Purple Biotech Market Cap
Purple Biotech has a market cap or net worth of $13.67 million as of July 26, 2024. Its market cap has decreased by -46.38% in one year.
Market Cap
13.67M
Enterprise Value
3.13M
1-Year Change
-46.38%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since November 20, 2015, Purple Biotech's market cap has increased from $11.20M to $13.67M, an increase of 22.09%. That is a compound annual growth rate of 2.32%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 25, 2024 | 10.00M | -35.48% |
Dec 29, 2023 | 15.50M | -36.99% |
Dec 30, 2022 | 24.60M | -63.77% |
Dec 31, 2021 | 67.90M | 805.33% |
Dec 31, 2020 | 7.50M | -40.00% |
Dec 31, 2019 | 12.50M | 68.92% |
Dec 31, 2018 | 7.40M | -57.71% |
Dec 29, 2017 | 17.50M | 44.63% |
Dec 30, 2016 | 12.10M | 9.01% |
Dec 31, 2015 | 11.10M | -0.89% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Immuron | 13.02M |
GeoVax Labs | 12.94M |
Guardion Health Sciences | 12.64M |
Psychemedics | 12.60M |
Sol-Gel Technologies | 12.53M |
Lumos Pharma | 12.50M |
Novo Integrated Sciences | 12.20M |
RedHill Biopharma | 12.11M |